Treatment of impacted cerumen: clinical effectiveness of a new cerumenolytic.
D001050:Apocrine Glands; D002571:Cerumen; D058113:Cerumenolytic Agents; D004194:Disease; D004424:Ear Canal; D004427:Ear Diseases; D004431:Ear, External; D006801:Humans; D013501:Surface-Active Agents / Q000627:therapeutic use*; D016896:Treatment Outcome
D058113:Cerumenolytic Agents; D013501:Surface-Active Agents
CERUMINOUS GLANDS; EAR, EXTERNAL/diseases; SURFACE-ACTIVE SUBSTANCES/therapeutic use